Biodesix appoints Dr. Jon Faiz Kayyem to board of directors effective December 6, 2021

BIODESIX INC

Dr. Kayyem brings 20+ years experience in molecular diagnostics, having founded GenMark Diagnostics and Clinical Micro Sensors.
Initial equity grant of $375,000: 50,368 NQSOs (5-year vest) and 31,619 RSUs (1-year vest).
Prorated annual grant of $87,397: 27,038 NQSOs vesting March 31, 2022, strike at close on December 7, 2021.
Appointed to Compensation Committee effective December 7, 2021; term expires at 2024 Annual Meeting.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Jon Faiz Kayyem

director

BDSX · BIODESIX INC

Effective: 2021-12-06
Filed: December 8, 2021, 6:59 PM ET

On December 6, 2021, Dr. Jon Faiz Kayyem was appointed to the Board of Directors of Biodesix, Inc. (the “Company”), effective December 6, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Jon Faiz Kayyem was appointed as director at BIODESIX INC.

Action: appointed
Role: director

Exact text from the filing

On December 6, 2021, Dr. Jon Faiz Kayyem was appointed to the Board of Directors of Biodesix, Inc. (the “Company”), effective December 6, 2021.

View on SEC.gov

BIODESIX INC filing history →

Source: SEC EDGAR

accession 0000950170-21-005077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.